Novelix Pharmaceuticals Board Meeting on Aug 13, 2026

Novelix Pharmaceuticals Ltd has announced a Board of Directors meeting scheduled for August 13, 2026. The primary agenda item is to consider and approve the unaudited standalone financial results for the quarter ended June 30, 2026, along with the auditor's limited review report. Additionally, the meeting will address any other matters with the chair's permission. In compliance with SEBI regulations and the company's insider trading code, the trading window for designated persons and their immediate relatives will be closed from July 1, 2026, until 48 hours after the board meeting concludes.